D3K2 Supports Healthy Vitamin D Levels
Total Page:16
File Type:pdf, Size:1020Kb
[email protected] www.biogenetix.com D3K2 Supports Healthy Vitamin D Levels Vitamin D has been shown in an ever-growing body of literature to support disease prevention and the maintenance of optimal health. Biogenetix D3K2 is a concentrated, synergistically blended Vitamin D/ Vitamin K formula for optimal absorption. Research suggests that if Vitamin D is to be dosed at therapeutic levels, Vitamin K is absolutely critical in proper application. Vitamin K has the all-important role of promoting proper Vitamin D utilization without causing calcification of muscles, arteries, or veins. Biogenetix uses natural Vitamin K2, called MK- 7, for optimal results. Use of Product: D3K2 provides a Supplement Facts Serving Size: 2 drops concentrated dosage of (0.08mL) Servings Per Container: 300 Vitamin D blended with Amount per Serving % Daily Value a complimentary balance Vitamin D (as cholecalciferol) 2000 IU 500% of Vitamin K2. Healthy Vitamin K2 (natural vitamin K2 as MK-7) 72mcg † vitamin D levels in the † Daily Value not established. body support numerous areas including: blood Other Ingredients: MCT oil (medium chain triglyceride oil from coconut/palm kernel oil), sugar metabolism, bone Sunflower Oil. health, immune health, cardiovascular health, DOES NOT CONTAIN: Sugar, wheat, casein, gluten, milk, autoimmune responses, neurodegenerative egg, yeast, preservatives, artificial flavorings, colorings, disorders, and many more. peanuts, tree nuts or fish. Formula Benefits: General Suggested Usage: Take as directed by your health care professional. • Support healthy vitamin D levels • Promote the dampening of arterial calcium build up • Promote proper blood sugar metabolism No Genetically and insulin receptor site sensitivity Engineered Ingredients • Support healthy immune system To be provided by health care professionals only. The dosage recommendations are only for your health care provider’s consideration. Please consult your health care provider for your individual dosing instructions. This product is for nutritional purposes only. It is not designed to diagnose, treat, reverse, cure, or prevent any disease. This product is not intended to replace or delay the use of prescrip- tion medication. These statements have not been evaluated by the FDA. All rights reserved © Biogenetix, LLC [email protected] www.biogenetix.com D3K2 References 1. Alti T, Gullu S, Usal AR, Erdogen G. The prevalence of vitamin D levels in the elderly of cancer mortality rates. Proceedings of the CIE symposium ’04; Light and Health: Turkish population. Arch Gerontol Geriatr 2005;40:53-60. non-visual effects, 30 Sept.-2 Oct. 2004. Commision International de L, Eclairage, 2. Atli T, Gullu S, Usal AR, Erdogan G. The prevalence of vitamin D deficiency and Vienna, Austria, 2004:174-177. effects of ultraviolet light on vitamin D levels in elderly Turkish population. Arch 28. Grant WB., Garland CF. A critical review of studies on vitamin D in relation to Gerontol Geriatr 2005;40:53-60. colorectal cancer. Nutr Cancer 2004;48:115-123. 3. Baker SB, Worthley LI, The essentials of calcium, magnesium and phosphate 29. Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr 2005; metabolism: part I. Physiology Department of Critical Care Medicine, Flinders 135:332-337. University of South Australia, Adelaide, South Australia (Crit Care Resusc. 2002 30. Hayas CE, Cantorna MT, DeLuca HF. Vitamin D and multiple sclerosis. Proc Soc Exp Dec;4(4):301-6.) Biol Medi 1997;216:21-27. 4. Bischoff-Ferrari HA, Conzelmann M, Dick W, et al. Effect of vitamin D on muscle 31. Hoick M. Vitamin D: importance in the prevention of cancers, type I diabetes, heart strength and relevance in regard to osteoporosis prevention. Z Rheumatol disease, and osteoporosis. Am J Clin Nutrition. 2004; 39:326-327. 2003;62:518-521. 32. Holick MF. Environment factors that influence the cutaneous production of vitamin D. 5. Campan P et al; Pilot study on n-3 polyunsaturated fatty acids in the treatment Am J Clin Nutr 1995;61:6838S-645S. of human experimental gingivitis. Departement de Chirurgie Buccale, Faculte de 33. Holick MF. Photosynthesis of vitamin D in the skin: effect of environmental and life- Chirurgie Dentaire de Toulouse, France. J Clin Periodontol. 1997 Dec;24(12):907- 13. style variables. Fed Proc 1987;46:1876-1882. 6. Cancer Chemoprevention and Cancer Treatment: is there a role for vitamin D, 34. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune 1alpha, 25(OH)2-vitamin D3, or new analogs (deltanois)? Bethesda, MD, November diseases, cancers, and cardiovascular diseases. Am J Clin Nutr 2004;80:1678S1688S. 17-19, 2004. Sponsored by the National Cancer Institute, NIH, The Vitamin D 35. Holick MF. Vitamin D deficiency: what pain it is. Mayo Clin Proc 2003;78:1457- 1459. Workshop, http://vitamined. ucr.edu/Cancer&CancerChemo.htm 36. Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type I 7. Cantorna MT, Zhu Y, Froicu M, Whittke A. Vitamin D status, 1-25-dihydroxyvitamin diabetes: a birth-cohort study. Lancet 2001; 358:1500-1503. D3, and the immune system. Am J Clin Nutr 37. Hypponen E. Micronutrients and risk of type I diabetes: vitamin D, vitamin E, and 8. Carpenter TO et al “Effect of magnesium depletion on metabolism of 25- nicotinamide. Nutr Rev 2004; 62:340-347. hydroxyvitamin D in rats” 38. Hypponens E, Lara E, Reunanen A, et al. Intake of vitamin D and risk of type I 9. Chandra R and Sudhakaran L. Regulation of immune responses by Vitamin B6. NY diabetes: a birth-cohort study. Lancet 2001;358:1500-1503. Acad Sci 1990; 585:404-423. 39. Koutkia P, Lu Z, Chen TC, Holick MF. Treatment of vitamin D deficiency due to 10. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an Crohn’s disease with tanning bed ultraviolet B radiation. Gastroeneterology 2001; adult normal population. Osteoporosis Int 1997;7:439-443. 121:1485-1488. 11. Chiu K, et al. Hypovitaminosis D is associated with insulin resistance and beta cell 40. Koziol JA. Feng AC. Seasonal variations in exacerbations and MRI parameters in function. Am J Clin Nutrition. 2004; 79: 820-825. relapsing remitting multiple sclerosis. Neuroepidemiology 2004; 23:217-223. 12. Cox SE et al; Vitamin A supplementation increases ratios of proinflammatory to 41. Leklem JE. Vitamin B6. In: Shils ME, Olson JA, Shike M, Ross AC, ed. Modern antiinflammatory cytokine responses in pregnancy and lactation. Department of Nutrition in Health and Disease. 9th ed. Baltimore: Williams and Wilkins, 1999: Epidemiology and Population Health, London School of Hygiene and Tropical 413-421. Medicine (LSHTM), London, UK.Clin Exp Immunol. 2006 Jun;144(3):392-400. 42. Leyland DM and Beynon RJ. The expression of glycogen phosphorylase in normal 13. Cross D, et al. Phytoestrogens and vitamin D metabolism: A new concept for and dystrophic muscle. Biochem J 1991; 278:113-7. the prevention and therapy of colorectal, prostate, and mammary carcinomas. J 43. Liu HX et al; Promotion of intestinal drug absorption by milk fat globule membrane Nutrition. 2004; 134: 127-1212. 2 Danilenko M, et al. Carnosic acid and promotion Department of Hospital Pharmacy, Toyama Medical and Pharmaceutical University, of monocytic differentiation of HL60-G cells initiated by other agents. J Natl Cancer Japan Yakugaku Zasshi. 1991 Sep;111(9):510-4 Inst. 2001, 93(16): 1224-1233. 44. Luo XM, “Retinoic acid exerts dual regulatory actions on the expression and 14. Dayong Wu and Simin Nikbin Meydan ; “ n-3 Polyunsaturated fatty acids and nuclear localization of interferon regulatory factor-1” Department of Nutritional immune function” Nutritional Immunology Laboratory, Jean Mayer USDA Human Sciences, 126-S Henderson Building, University Park, PA 16802, USA, Exp Biol Med Nutrition Research Center on Aging at TUBS University,Boston, Proceedings of the (Maywood). 2006 May;231(5):619-31 Nutrition Society (1998), 57, 503-509 45. Lyakh LA, Sanford M, Chekol S, et al. TGF beta and vitamin D3 utilize distinct 15. DeLuca HF, Cantorna MT. Vitamin D:its role and uses in immunology. FASEB J pathways to suppress IL-12 production and modulate rapid differentiation of 2001;15:2579-2585. monocytes into CD83+ dendritic cells. J Immunol 2005;174:2061-2070. 16. Drugarin D. The pattern of Th1 cytokine in autoimmune thyroditis. Immunol Letts, 46. Mazur A et al, Magnesium and the inflammatory response: Potential 2000; 71: 73-77. physiopathological implications Equipe Stress Metabolique et Micronutriments, 17. Embroy AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium- Unite de Nutrition Humaine UMR 1019, Centre de Recherche en Nutrition Humaine enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol d’Auvergne, INRA, Theix, St. Genes Champanelle, France. Arch Biochem Biophys. 2000;48:271- 272. 2006 Apr 19 18. Embroy AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium- 47. Moore C, Murphy MM, Keast DR, Holick MF. Vitamin D intake in the United States. J enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol AM Diet Assoc 2004;104:980-983. 2000;48:271-271. 48. Moschakis T et al: Microstructural evolution of viscoelastic emulsions stabilised by 19. Embroy AF. Vitamin D supplementation in the fight against multiple sclerosis. J sodium caseinate and xanthan gum Procter Department of Food Science, University Orthomolecular Med 2004;19:27-38. of Leeds, Leeds LS2 9JT, UK J Colloid Interface Sci. 2005 Apr 15;284(2):714-28 20. Embry AF. Vitamin D supplementation in the fight against multiple sclerosis. J 49. Okada M, Ishikawa K, Watanabe K. Effect of vitamin B6 deficiency on glycogen Orthomolecular Med 2004; 19:27-38. metabolism in the skeletal muscle, heart, and liver of rats. J Nutr Sci Vitaminol 21. Ericksen EF, Glenrup H. Vitamin D deficiency and aging: implications for general (Tokyo) 1991; 37:349-57.